Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2547

Numab extends its Series C; AnaCardio raises $19M for its heart failure drug

$
0
0
Plus, news about RheumaGen and RyboDyn: Numab Therapeutics brings in $55M: The Swiss biotech extended its Series C, originally disclosed in ...

Viewing all articles
Browse latest Browse all 2547

Trending Articles